Skip to main content
. 2016 Jul 20;19(7):418–424. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2016.07.03

2.

Masaoka分期为晚期时两组患者的相关资料

The specific analysis of late Masaoka stage patients between two groups

MG (n=142) non-MG (n=605) P
注:本表得到版权所有者©2011-2016 Journal of Thoracic Disease复制许可。
Masaoka stage 0.128
  Ⅲ 116 (81.7%) 458 (75.7%)
  Ⅳ 26(18.3%) 147 (24.3%)
WHO classification < 0.001
  A 2 (1.4%) 14 (2.3%)
  AB 15 (10.6%) 38 (6.3%)
  B1 19 (13.4%) 29 (4.8%)
  B2 39 (27.5%) 71 (11.7%)
  B3 54 (38.0%) 154(25.5%)
  C 13 (9.2%) 273 (45.1%)
  Carcinoid 0 (0.0%) 26 (4.3%)
Complete thymectomy 122 (86.5%) 434 (72.7%) 0.001
Tumor size 6.4 7.9 < 0.001
Resectability 104(73.2%) 400 (66.4%) 0.119
Recurrence 16(15.7%) 137 (31.7%) 0.001